Key Highlights
- Closed Life Sciences Pulse Fund III with $555 million, reaching $1.3 billion across three funds.
- Fund to invest in private therapeutics, diagnostics, medical devices, and life sciences tools.
- Strong investor interest with a mix of new and returning partners.
Source: Business Wire
Notable Quote
- “The life sciences sector continues to innovate at a rapid pace, leading to breakthroughs that benefit both patients and society as a whole,” – Stephen Zachary, Managing Partner at Sands Capital
SoHC's Take
Sands Capital’s strategic approach to investing in life sciences showcases its commitment to fostering innovation and supporting transformative technologies in healthcare. With a significant amount of managed assets and a dedicated team of industry professionals, Sands Capital is poised to make impactful contributions in defining, diagnosing, and treating diseases. Their long-term, growth-focused investment philosophy ensures they remain at the forefront of supporting groundbreaking advancements in the life sciences sector.
